tiprankstipranks
Trending News
More News >
InnoCare Pharma Ltd. (HK:9969)
:9969

Compare InnoCare Pharma Ltd. (9969) vs. Competitors

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
InnoCare Pharma Ltd.
HK$11.62
HK$17.44B
-82.29
110.16%
4 Buy
1 Hold
0 Sell
Strong Buy
Everest Medicines Ltd.
HK$51.50
HK$14.32B
-18.15
-1.24%
Keymed Biosciences, Inc.
HK$62.80
HK$16.21B
-54.55
89.15%
3 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$9.19B
-15.58
53.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Henlius Biotech, Inc. Class H
HK$58.60
HK$31.90B
35.30
244.87%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$50.90
HK$18.26B
-12.51
44.45%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9969
InnoCare Pharma Ltd.
11.62
6.09
110.16%
HK:1952
Everest Medicines Ltd.
39.80
-1.35
-3.28%
HK:2162
Keymed Biosciences, Inc.
55.80
26.65
91.42%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.49
5.41
53.67%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
57.80
40.82
240.40%
HK:6855
Ascentage Pharma Group International
49.04
13.34
37.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts